A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2015; you can also visit the original URL.
The file type is
Improved Viral Suppression After Treatment Optimization in HIV-Infected Patients With Persistent Low-Level Viremia
Journal of Acquired Immune Deficiency Syndromes
Optimizing treatment for patients with persistent lowlevel viremia is complicated because most genotyping tests are validated for viral loads .1000 copies per milliliter. In this study, genotypes of 92 treatment-experienced patients with persistent lowlevel viremia were determined using an in-house assay. Based on the resistance profiles obtained from genotyping and patient pharmacologic history, patients were either maintained on their antiviral regimen (n = 51) or received an optimizeddoi:10.1097/qai.0b013e3182364513 pmid:21963935 fatcat:md76ntmnwfcx5m644reefynxj4